NCT00096005 2014-02-24Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasNational Cancer Institute (NCI)Phase 1 Terminated36 enrolled
NCT00354185 2013-05-16PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Terminated36 enrolled
NCT00004241 2013-02-0717-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaNational Cancer Institute (NCI)Phase 1 Completed60 enrolled
NCT00004075 2011-08-0317-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryMayo ClinicPhase 1 Completed